Dr. Michael Symalla

Dr. Michael Symalla has an extensive professional background in development and project management within the medical technology and data security sectors. Currently serving as an Investor and Mentor at Aktien mit Schmackes since September 2023, Dr. Symalla has held the position of Entwicklungsleiter Strahlentherapie at Carl Zeiss Meditec AG since 2011. Additionally, since 2017, Dr. Symalla has contributed to Datenwache by focusing on data security for small businesses and promoting security awareness. Previously, Dr. Symalla managed large-scale projects involving particle accelerator ion therapy at Siemens Healthineers and was involved in software development at Beckhoff Automation. Academically, Dr. Michael Symalla earned a doctoral degree in physics from TU Dortmund University.